Jennifer Burstein, Senior VP of Finance at Loxo Oncology, Inc. (LOXO), sold 2,500 shares at $151.57 ($369K) on 2018-11-26, disclosed to the SEC on 2018-11-28.
Open-market sale of $369k LOXO by Senior VP of Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.57 | 500 | $76K | 20.5% |
| 2 | $152.39 | 250 | $38K | 10.3% |
| 3 | $153.30 | 100 | $15K | 4.2% |
| 4 | $155.13 | 300 | $47K | 12.6% |
| 5 | $156.04 | 100 | $16K | 4.2% |
| 6 | $137.89 | 200 |
| $28K |
| 7.5% |
| 7 | $138.95 | 350 | $49K | 13.2% |
| 8 | $140.94 | 200 | $28K | 7.6% |
| 9 | $143.84 | 200 | $29K | 7.8% |
| 10 | $147.09 | 100 | $15K | 4.0% |
| 11 | $148.20 | 100 | $15K | 4.0% |
| 12 | $151.55 | 100 | $15K | 4.1% |
| Total | $147.68 avg | 2,500 | $369K | 100% |
| Filing → |
| LOXO | SELL | 2018-09-14 | $667K | — | Filing → |
| LOXO | SELL | 2018-08-15 | $540K | — | Filing → |
| LOXO | SELL | 2018-07-11 | $281K | — | Filing → |